Search research articles
Contact Us
Filters
Showing results (441-450 of 515) with videos related to
Page
of 52
Sort By:
International Journal of Cancer
|
May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients
Rui You, You-Ping Liu, Mei Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
Li-Ting Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the American Chemical Society
|
August 6, 2019
Folding and Assembly of Short α, β, γ-Hybrid Peptides: Minor Variations in Sequence and Drastic Differences in Higher-Level Structures
Yukun Zhang, Yulong Zhong, Alan L Connor, et al.
BMC Cancer
|
December 22, 2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Cell Reports
|
July 3, 2025
OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression
Shi-Bing Li, Li Yuan, Qian-Ying Zhu, et al.
The Lancet Regional Health. Western Pacific
|
September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial
Dong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
BMC Cancer
|
February 5, 2020
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level
Sai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, et al.
Cancer Research and Treatment
|
April 11, 2017
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
JAMA Network Open
|
December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial
Qing-Nan Tang, Li-Ting Liu, Bin Qi, et al.
Page
of 52
Search research articles
Search
Showing results (441-450 of 515) with videos related to
Sort By:
Page
of 52
International Journal of Cancer
|
May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients
Rui You, You-Ping Liu, Mei Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
Li-Ting Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the American Chemical Society
|
August 6, 2019
Folding and Assembly of Short α, β, γ-Hybrid Peptides: Minor Variations in Sequence and Drastic Differences in Higher-Level Structures
Yukun Zhang, Yulong Zhong, Alan L Connor, et al.
BMC Cancer
|
December 22, 2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Cell Reports
|
July 3, 2025
OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression
Shi-Bing Li, Li Yuan, Qian-Ying Zhu, et al.
The Lancet Regional Health. Western Pacific
|
September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial
Dong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
BMC Cancer
|
February 5, 2020
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level
Sai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, et al.
Cancer Research and Treatment
|
April 11, 2017
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
JAMA Network Open
|
December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial
Qing-Nan Tang, Li-Ting Liu, Bin Qi, et al.
Page
of 52